These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives. Treska V Anticancer Res; 2016 May; 36(5):2065-71. PubMed ID: 27127106 [TBL] [Abstract][Full Text] [Related]
5. Portal Vein Embolization with Contralateral Application of Stem Cells Facilitates Increase of Future Liver Remnant Volume in Patients with Liver Metastases. Ludvík J; Duras P; Třeška V; Matoušková T; Brůha J; Fichtl J; Lysák D; Ferda J; Baxa J Cardiovasc Intervent Radiol; 2017 May; 40(5):690-696. PubMed ID: 28091729 [TBL] [Abstract][Full Text] [Related]
6. Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application. Fichtl J; Treska V; Lysak D; Mirka H; Duras P; Karlikova M; Skalicky T; Vodička J; Topolcan O Anticancer Res; 2016 Apr; 36(4):1901-7. PubMed ID: 27069178 [TBL] [Abstract][Full Text] [Related]
8. Pros and Cons of Portal Vein Embolization With Hematopoietic Stem Cells Application in Colorectal Liver Metastases Surgery. Treska V; Bruha J; Liska V; Fichtl J; Prochazkova K; Petrakova T; Hosek P In Vivo; 2020; 34(5):2919-2925. PubMed ID: 32871833 [TBL] [Abstract][Full Text] [Related]
9. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study. Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548 [TBL] [Abstract][Full Text] [Related]
10. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Fürst G; Schulte am Esch J; Poll LW; Hosch SB; Fritz LB; Klein M; Godehardt E; Krieg A; Wecker B; Stoldt V; Stockschläder M; Eisenberger CF; Mödder U; Knoefel WT Radiology; 2007 Apr; 243(1):171-9. PubMed ID: 17312278 [TBL] [Abstract][Full Text] [Related]
11. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Oussoultzoglou E; Bachellier P; Rosso E; Scurtu R; Lucescu I; Greget M; Jaeck D Ann Surg; 2006 Jul; 244(1):71-9. PubMed ID: 16794391 [TBL] [Abstract][Full Text] [Related]
12. In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection. Lehwald-Tywuschik N; Vaghiri S; Schulte Am Esch J; Alaghmand S; Klosterkemper Y; Schimmöller L; Lachenmayer A; Ashmawy H; Krieg A; Topp SA; Rehders A; Knoefel WT BMC Surg; 2020 Apr; 20(1):63. PubMed ID: 32252737 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases. Yamashita S; Sakamoto Y; Yamamoto S; Takemura N; Omichi K; Shinkawa H; Mori K; Kaneko J; Akamatsu N; Arita J; Hasegawa K; Kokudo N Ann Surg Oncol; 2017 Jun; 24(6):1557-1568. PubMed ID: 28188502 [TBL] [Abstract][Full Text] [Related]
14. [Stem cell-induced liver regeneration]. Knoefel WT; Alexander A; Tustas RY; Schmelzle M; Klein HM; Krieg A; Topp SA; Eisenberger CF; Fuerst G; Schulte am Esch J Zentralbl Chir; 2013 Apr; 138(2):166-72. PubMed ID: 22086774 [TBL] [Abstract][Full Text] [Related]
15. [Portal vein embolization--increased chance for liver resecability for malignancies]. Liska V; Treska V; Mírka H; Novák M; Slauf F; Skalický T; Sutnar A; Kormunda S Rozhl Chir; 2007 Feb; 86(2):97-101; discussion 102. PubMed ID: 17436675 [TBL] [Abstract][Full Text] [Related]
16. Tumor progression after preoperative portal vein embolization. Hoekstra LT; van Lienden KP; Doets A; Busch OR; Gouma DJ; van Gulik TM Ann Surg; 2012 Nov; 256(5):812-7; discussion 817-8. PubMed ID: 23095626 [TBL] [Abstract][Full Text] [Related]
17. Future liver remnant hypertrophy rate in portal vein embolization before left trisectionectomy: a retrospective cohort study. Onishi Y; Isoda H; Ohno T; Shimizu H; Shimada K; Taura K; Hatano E; Nakamoto Y Abdom Radiol (NY); 2022 Feb; 47(2):878-884. PubMed ID: 34958405 [TBL] [Abstract][Full Text] [Related]
18. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138 [TBL] [Abstract][Full Text] [Related]
19. Long-term remnant liver volume dynamics after major hepatectomy for perihilar cholangiocarcinoma following portal vein embolization. Yamazaki S; Shimizu A; Kubota K; Notake T; Kitagawa N; Masuo H; Yoshizawa T; Sakai H; Hirano S; Soejima Y Asian J Surg; 2024 Sep; 47(9):3870-3876. PubMed ID: 38688761 [TBL] [Abstract][Full Text] [Related]
20. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Wicherts DA; de Haas RJ; Andreani P; Sotirov D; Salloum C; Castaing D; Adam R; Azoulay D Br J Surg; 2010 Feb; 97(2):240-50. PubMed ID: 20087967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]